Page last updated: 2024-11-04

sulfinpyrazone and Hip Fractures

sulfinpyrazone has been researched along with Hip Fractures in 1 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Hip Fractures: Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rogers, PH1
Walsh, PN1
Marder, VJ1
Bosak, GC1
Lachman, JW1
Ritchie, WG1
Oppenheimer, L1
Sherry, S1

Trials

1 trial available for sulfinpyrazone and Hip Fractures

ArticleYear
Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip.
    The Journal of bone and joint surgery. American volume, 1978, Volume: 60, Issue:6

    Topics: Administration, Oral; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heparin; Hi

1978